Luis A. Diaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luis A. Diaz has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Zhi Liu
Department of Dermatology, University of North Carolina , Chapel Hill, NC
4 shared publications Ning Li
Department of Dermatology, University of North Carolina at Chapel Hill , Chapel Hill, NC 27599
3 shared publications- Paul B. Googe
Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA
3 shared publications Bin-Jin Hwang
Department of Dermatology, University of North Carolina at Chapel Hill , Chapel Hill, NC 27599
2 shared publicationsJinbo Chen
Department of Dermatology, University of North Carolina at Chapel Hill , Chapel Hill, NC
2 shared publications- Nancy E. Thomas
University of North Carolina at Chapel Hill
2 shared publications
Latest Publications
- 18 October 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (12) , 2611-2613
Lowell A. Goldsmith: Physician, Scientist, Educator, Mentor, Friend (March 29, 1938–July 10, 2024)
- 18 October 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (12) , 2611-2613
Lowell A. Goldsmith: Physician, Scientist, Educator, Mentor, Friend (March 29, 1938–July 10, 2024)
- 6 September 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 211 (8) , 1216-1223
The Eotaxin-1/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid
Bullous pemphigoid (BP) is the most common autoimmune bullous skin disease of humans and is characterized by eosinophilic inflammation and circulating and tissue-bound IgG and IgE autoantibodies directed against two hemidesmosomal proteins: BP180 and BP230. The noncollagenous 16A domain (NC16A) of BP180 has been found to contain major epitopes recognized by autoantibodies in BP. We recently established the pathogenicity of anti-NC16A IgE through passive transfer of patient-derived autoantibodies to double-humanized mice that express the human high-affinity IgE receptor, FcεRI, and human NC16A domain (FcεRI/NC16A). In this model, anti-NC16A IgEs recruit eosinophils to mediate tissue injury and clinical disease in FcεRI/NC16A mice. The objective of this study was to characterize the molecular and cellular events that underlie eosinophil recruitment and eosinophil-dependent tissue injury in anti-NC16A IgE-induced BP. We show that anti-NC16A IgEs significantly increase levels of key eosinophil chemoattractants, eotaxin-1 and eotaxin-2, as well as the proteolytic enzyme matrix metalloproteinase-9 (MMP-9) in the lesional skin of FcεRI/NC16A mice. Importantly, neutralization of eotaxin-1, but not eotaxin-2, and blockade of the main eotaxin receptor, CCR3, drastically reduce anti-NC16A IgE-induced disease activity. We further show that anti-NC16A IgE/NC16A immune complexes induce the release of MMP-9 from eosinophils, and that MMP-9–deficient mice are resistant to anti-NC16A IgE-induced BP. Lastly, we find significantly increased levels of eotaxin-1, eotaxin-2, and MMP-9 in blister fluids of BP patients. Taken together, this study establishes the eotaxin-1/CCR3 axis and MMP-9 as key players in anti-NC16A IgE-induced BP and candidate therapeutic targets for future drug development and testing.
- 6 September 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 211 (8) , 1216-1223
The Eotaxin-1/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid
Bullous pemphigoid (BP) is the most common autoimmune bullous skin disease of humans and is characterized by eosinophilic inflammation and circulating and tissue-bound IgG and IgE autoantibodies directed against two hemidesmosomal proteins: BP180 and BP230. The noncollagenous 16A domain (NC16A) of BP180 has been found to contain major epitopes recognized by autoantibodies in BP. We recently established the pathogenicity of anti-NC16A IgE through passive transfer of patient-derived autoantibodies to double-humanized mice that express the human high-affinity IgE receptor, FcεRI, and human NC16A domain (FcεRI/NC16A). In this model, anti-NC16A IgEs recruit eosinophils to mediate tissue injury and clinical disease in FcεRI/NC16A mice. The objective of this study was to characterize the molecular and cellular events that underlie eosinophil recruitment and eosinophil-dependent tissue injury in anti-NC16A IgE-induced BP. We show that anti-NC16A IgEs significantly increase levels of key eosinophil chemoattractants, eotaxin-1 and eotaxin-2, as well as the proteolytic enzyme matrix metalloproteinase-9 (MMP-9) in the lesional skin of FcεRI/NC16A mice. Importantly, neutralization of eotaxin-1, but not eotaxin-2, and blockade of the main eotaxin receptor, CCR3, drastically reduce anti-NC16A IgE-induced disease activity. We further show that anti-NC16A IgE/NC16A immune complexes induce the release of MMP-9 from eosinophils, and that MMP-9–deficient mice are resistant to anti-NC16A IgE-induced BP. Lastly, we find significantly increased levels of eotaxin-1, eotaxin-2, and MMP-9 in blister fluids of BP patients. Taken together, this study establishes the eotaxin-1/CCR3 axis and MMP-9 as key players in anti-NC16A IgE-induced BP and candidate therapeutic targets for future drug development and testing.
- 10 July 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (1) , 24-32.e1
Anti-NC16A IgA from Patients with Linear IgA Bullous Dermatosis Induce Neutrophil-Dependent Subepidermal Blistering in Mice
- 10 July 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (1) , 24-32.e1
Anti-NC16A IgA from Patients with Linear IgA Bullous Dermatosis Induce Neutrophil-Dependent Subepidermal Blistering in Mice
- 15 November 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 205 (10) , 2786-2794
Non–Cell-Autonomous Activity of the Hemidesmosomal Protein BP180/Collagen XVII in Granulopoiesis in Humanized NC16A Mice
BP180 (also termed type XVII collagen) is a hemidesmosomal protein and plays a critical role in cell–cell matrix adhesion in the skin; however, its other biological functions are largely unclear. In this study, we generated a BP180 functional–deficient mouse strain by deleting its extracellular domain of humanized NC16A (termed ΔNC16A mice). We found that BP180 is expressed by bone marrow mesenchymal stem cells (BM-MSC), and its functional deficiency leads to myeloid hyperplasia. Altered granulopoiesis in ΔNC16A mice is through bone marrow stromal cells evidenced by bone marrow transplantation. Furthermore, the level of G-CSF in bone marrow and circulation were significantly increased in ΔNC16A mice as compared with wild-type mice. The increased G-CSF was accompanied by an increased activation of the NF-κB signaling pathway in bone marrow and BM-MSC of ΔNC16A mice. Blockade of G-CSF restored normal granulopoiesis in ΔNC16A mice. Inhibition of NF-κB signaling pathway significantly reduces the release of G-CSF from ΔNC16A BM-MSC in vitro and the level of serum G-CSF in ΔNC16A mice. To our knowledge, these findings provide the first direct evidence that BP180 plays an important role in granulopoiesis through regulating NF-κB signaling pathway in BM-MSC. Key Points BP180 is expressed in bone marrow mesenchymal stem cells. BP180 in bone marrow mesenchymal stem cells regulates granulopoiesis.
- 15 November 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 205 (10) , 2786-2794
Non–Cell-Autonomous Activity of the Hemidesmosomal Protein BP180/Collagen XVII in Granulopoiesis in Humanized NC16A Mice
BP180 (also termed type XVII collagen) is a hemidesmosomal protein and plays a critical role in cell–cell matrix adhesion in the skin; however, its other biological functions are largely unclear. In this study, we generated a BP180 functional–deficient mouse strain by deleting its extracellular domain of humanized NC16A (termed ΔNC16A mice). We found that BP180 is expressed by bone marrow mesenchymal stem cells (BM-MSC), and its functional deficiency leads to myeloid hyperplasia. Altered granulopoiesis in ΔNC16A mice is through bone marrow stromal cells evidenced by bone marrow transplantation. Furthermore, the level of G-CSF in bone marrow and circulation were significantly increased in ΔNC16A mice as compared with wild-type mice. The increased G-CSF was accompanied by an increased activation of the NF-κB signaling pathway in bone marrow and BM-MSC of ΔNC16A mice. Blockade of G-CSF restored normal granulopoiesis in ΔNC16A mice. Inhibition of NF-κB signaling pathway significantly reduces the release of G-CSF from ΔNC16A BM-MSC in vitro and the level of serum G-CSF in ΔNC16A mice. To our knowledge, these findings provide the first direct evidence that BP180 plays an important role in granulopoiesis through regulating NF-κB signaling pathway in BM-MSC. Key Points BP180 is expressed in bone marrow mesenchymal stem cells. BP180 in bone marrow mesenchymal stem cells regulates granulopoiesis.
- 4 June 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (25) , 6434-6439
BP180 dysfunction triggers spontaneous skin inflammation in mice
Significance: BP180 is a cell–cell matrix adhesion molecule and is critical for attachment of epidermis to underlying dermis. We generated a dysfunctional BP180 mouse strain (Δ NC16A mice). The Δ NC16A mice at 8 weeks start developing spontaneous itch and skin inflammation characterized by increased skin thickness, infiltrating immune cells, increased levels of IgE in circulation, proinflammatory mediators in the skin, and impaired skin barrier. Bullous pemphigoid (BP) patients also present increased TSLP in lesional skin and circulation. Our findings suggest that BP180 regulates pruritic skin inflammation. Elucidation of molecular and cellular mechanisms underlying the role of BP180 in skin inflammation should help better understanding of pathophysiology of skin inflammation and identify therapeutic targets for skin inflammatory diseases such as BP and atopic dermatitis.
- 4 June 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (25) , 6434-6439
BP180 dysfunction triggers spontaneous skin inflammation in mice
Significance: BP180 is a cell–cell matrix adhesion molecule and is critical for attachment of epidermis to underlying dermis. We generated a dysfunctional BP180 mouse strain (Δ NC16A mice). The Δ NC16A mice at 8 weeks start developing spontaneous itch and skin inflammation characterized by increased skin thickness, infiltrating immune cells, increased levels of IgE in circulation, proinflammatory mediators in the skin, and impaired skin barrier. Bullous pemphigoid (BP) patients also present increased TSLP in lesional skin and circulation. Our findings suggest that BP180 regulates pruritic skin inflammation. Elucidation of molecular and cellular mechanisms underlying the role of BP180 in skin inflammation should help better understanding of pathophysiology of skin inflammation and identify therapeutic targets for skin inflammatory diseases such as BP and atopic dermatitis.
- 1 May 2018
- Published by Elsevier in Journal of Autoimmunity
- Vol. 89, 171-185
Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope
- 1 May 2018
- Published by Elsevier in Journal of Autoimmunity
- Vol. 89, 171-185
Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope